Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Friday, March 29, 2024 · 699,678,146 Articles · 3+ Million Readers

Japan In Vitro Diagnostics (IVD) Market 2018-2024

Dublin, Oct. 15, 2018 (GLOBE NEWSWIRE) -- The "Japan In Vitro Diagnostics (IVD) Market, By Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Challenges, Opportunities" report has been added to ResearchAndMarkets.com's offering.

The Japanese In Vitro Diagnostics market is expected to surpass US$ 4.3 Billion by the end of year 2024.

In Japan, In Vitro Diagnostics comes under medical devices, which are consumable or disposable and used to collect numerous bio-samples under various medical conditions.

Japan has the highest proportion of ageing population globally; almost its quarter of population is aged 65 and over. The rise in number of older people is the biggest burden for the Japanese government because the prevalence of ageing diseases is rising at rapid pace. So the Japanese government has given priority to deal with ageing population and it is expected that the government will allocate an increased healthcare budget in 2025 for ageing. Therefore rising prevalence and increased public expenditure will boost the Japanese In Vitro Diagnostics Market in future.

This report includes an in-depth study of 11 segments of Japan In Vitro Diagnostic Market: Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology, Genetic Testing and Others. The report gives you comprehensive insight of each segment of In-vitro diagnostic along with separate growth factors for each of segments.

This report explains the length and breadth of reimbursement policies along with the complete framework. It also provides clear insight & structure of how it works actually, how to take approval from Japanese authorities regarding reimbursement policies. It explains classification of medical devices in Japan and which class In vitro diagnostic fits. It covers all medical manufacturer applied for reimbursement approval in Japan for past five years.

The advancement in In vitro Diagnostic technique has made it simpler to diagnose with lesser time being less invasive. The improved digitization in pathology has gain the ability to deliver the clinical outcome within the stipulated time-frame. Japan has successfully done the trial for first urine test to diagnose cancer in the world in 2018. Moreover for colon cancer, screening is conducted via a feces test. All these technology improvement will further enhance the Japan In vitro Diagnostic market.

In this report, we provide in-depth analysis of all five forces and their significant impact on market supply and demand of Japan In-vitro Diagnostic products.

Key Topics Covered:

1. Introduction
1.1 Market Definition
1.2 Currency Conversion

2. Research Methodology

3. Executive Summary

4. Market Outlook - Japan In-vitro Diagnostics Market

5. Market Share Analysis

6. Japan In-vitro Diagnostics Market by Segment
6.1 Urine & Faces Diagnostics
6.2 Hematology
6.3 Clinical Chemistry
6.4 Self-Blood Glucose Monitoring
6.5 Tumor Marker
6.6 Immunology
6.7 Infectious Testing
6.8 Microbiology
6.9 Pathology
6.10 Genetic Testing
6.11 Others

7. Porter's Five Forces Analysis
7.1 Threat of New Entry
7.2 The Bargaining Power of Buyer
7.3 Threat of Substitution
7.4 The Bargaining Power of Supplier
7.5 Competitive Rivalry

8. Market Dynamics
8.1 Growth Drivers
8.2 Challenges
8.3 Opportunities

9. Reimbursement Policy

10. Abbott Laboratories - Company Analysis
10.1 Company Overview
10.2 Company Initiatives
10.3 Financial Insight

11. Danaher Corporation - Company Analysis
11.1 Company Overview
11.2 Company Initiatives
11.3 Financial Insight

12. Biomerieux - Company Analysis
12.1 Company Overview
12.2 Company Initiatives
12.3 Financial Insight

13. Roche Diagnostics - Company Analysis
13.1 Company Overview
13.2 Company Initiatives
13.3 Financial Insight

For more information about this report visit https://www.researchandmarkets.com/research/ljf6nk/japan_in_vitro?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: In Vitro Diagnostics
                    

22157.jpg

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release